KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Cash & Equivalents (2016 - 2025)

Zoetis (ZTS) has disclosed Cash & Equivalents for 13 consecutive years, with $2.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 21.59% to $2.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 billion, a 21.59% increase, with the full-year FY2024 number at $2.0 billion, down 2.65% from a year prior.
  • Cash & Equivalents was $2.1 billion for Q3 2025 at Zoetis, up from $1.4 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $3.7 billion in Q2 2021 to a low of $1.4 billion in Q2 2025.
  • A 5-year average of $2.4 billion and a median of $2.1 billion in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 84.62% in 2021, then plummeted 43.0% in 2023.
  • Zoetis' Cash & Equivalents stood at $3.5 billion in 2021, then grew by 2.75% to $3.6 billion in 2022, then tumbled by 43.0% to $2.0 billion in 2023, then dropped by 2.65% to $2.0 billion in 2024, then increased by 4.88% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Cash & Equivalents are $2.1 billion (Q3 2025), $1.4 billion (Q2 2025), and $1.7 billion (Q1 2025).